The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Bcl-2–dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis
Open accessAbstract
The close association between autoantibodies against pyruvate dehydrogenase-E2 (PDC-E2), a ubiquitous mitochondrial protein, and primary biliary cirrhosis (PBC) is unexplained.Many autoantigens are selectively modified during apoptosis, which has focused attention on apoptotic cells as a potential source of "neo-antigens" responsible for activating autoreactive lymphocytes.Since increased apoptosis of bile duct epithelial cells (cholangiocytes) is evident in patients with PBC, we evaluated the effect of apoptosis on PDC-E2.Autoantibody recognition of PDC-E2 by immunofluorescence persisted in apoptotic cholangiocytes and appeared unchanged by immunoblot analysis.PDC-E2 was neither cleaved by caspases nor concentrated into surface blebs in apoptotic cells.In other cell types, autoantibody recognition of PDC-E2, as assessed by immunofluorescence, was abrogated after apoptosis, although expression levels of PDC-E2 appeared unchanged when examined by immunoblot analysis.Both overexpression of Bcl-2 and depletion of glutathione before inducing apoptosis prevented this loss of autoantibody recognition, suggesting that glutathiolation, rather than degradation or loss, of PDC-E2 was responsible for the loss of immunofluorescence signal.We postulate that apoptotic cholangiocytes, unlike other apoptotic cell types, are a potential source of immunogenic PDC-E2 in patients with PBC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The oxidation of mitochondrial epitopes during apoptosis might lead to formation of neoantigens that are recognized by anti-mitochondrial antibodies228.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [228]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, O. W. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90139-6 · Cited by 4,628
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,402
Casciola-Rosen, L. A., Anhalt, G. J., & Rosen, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,723
Self-citationSauter, B., Albert, M. L., Francisco, L. M., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,357
Huang, F., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., & MacPherson, G. G. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.435 · Cited by 902
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Gershwin, M. E., Mackay, I. R., Sturgess, A., & Coppel, R. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3525 · Cited by 557
Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status
Casciola-Rosen, L. A., Andrade, F., Ulanet, D., Wong, W. B., & Rosen, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.815 · Cited by 492
Self-citationBallardini, G., Bianchi, F., Doniach, D., Mirakian, R. M., Pisi, E., & Bottazzo, G. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91108-5 · Cited by 488
Research works printed but not linked: 11
- Culp, 1982, Mayo Clin Proc, 57, 365
- Tsujimoto, 1997, Leukemia, 11(Suppl. 3), 380
- Charlotte, 1994, Am J Pathol, 144, 460
- Vroman, 1996, Lab Invest, 74, 303
- Watson, 1991, Am J Physiol, 261, G229
- Alpini, 1998, Am J Physiol, 274, G767
- Mendel-Hartvig, 1985, Clin Exp Immunol, 62, 371
- Celli, 1998, Am J Physiol, 275, G749
- Que, 1997, Am J Physiol, 272, G106
- Dini, 2000, Eur J Histochem, 44, 217
- Schultheiss, 1983, Clin Exp Immunol, 54, 648
Cited by
Sorted by citations
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Carey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Kaplowitz, N. (2004) · Clinical Infectious Diseases · doi:10.1086/381446 · Cited by 402
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61965-4 · Cited by 334
Patients With Primary Biliary Cirrhosis React Against A Ubiquitous Xenobiotic–Metabolizing Bacterium
Selmi, C., Balkwill, D. L., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S., Kenny, T. P., Van De Water, J., Nantz, M. H., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50446 · Cited by 312
Talwalkar, J. A., & Lindor, K. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13808-1 · Cited by 300
Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis
Iorga, A., Dara, L., & Kaplowitz, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051018 · Cited by 305
Pathogenesis of cholestatic liver disease and therapeutic approaches
Hirschfield, G. M., Heathcote, E. J., & Gershwin, M. E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.004 · Cited by 287
The causes of primary biliary cirrhosis: Convenient and inconvenient truths
Gershwin, E. M., & Mackay, I. R. (2007) · Hepatology · doi:10.1002/hep.22042 · Cited by 273
Primary biliary cirrhosis: A 2010 update
Poupon, R. Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.027 · Cited by 273
Tabibian, J. H., Masyuk, A. I., Masyuk, T. V., O'Hara, S. P., & LaRusso, N. F. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00495.x · Cited by 52
Self-citationThe role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer
Tew, K. D., Manevich, Y., Grek, C. L., Xiong, Y., Uys, J. D. K., & Townsend, D. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.013 · Cited by 239
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
Glutathione S-Transferases in Cancer
Singh, R. R., & Reindl, K. M. (2021) · Antioxidants · doi:10.3390/antiox10050701 · Cited by 245
Apotopes and the biliary specificity of primary biliary cirrhosis†
Lleo, A., Selmi, C., Invernizzi, P., Podda, M., Coppel, R. L., Mackay, I. R., Gores, G. J., Ansari, A. A., Van de Water, J., & Gershwin, M. E. (2009) · Hepatology · doi:10.1002/hep.22736 · Cited by 222
Lleò, A., Bowlus, C. L., Yang, G., Invernizzi, P., Podda, M., de Water, J. V., Ansari, A. A., Coppel, R. L., Worman, H. J., Gores, G. J., et al. (2010) · Hepatology · doi:10.1002/hep.23783 · Cited by 215
Diagnosis and Management of Primary Biliary Cholangitis
Younossi, Z. M., Bernstein, D., Shiffman, M. L., Kwo, P. Y., Kim, W. R., Kowdley, K. V., & Jacobson, I. M. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0390-3 · Cited by 220
S-Glutathionylation: Indicator of Cell Stress and Regulator of the Unfolded Protein Response
Townsend, D. M. (2007) · Molecular Interventions · doi:10.1124/mi.7.6.7 · Cited by 206
Glutathionylation of Mitochondrial Proteins
Hurd, T. R., Costa, N. J., Dahm, C. C., Beer, S. M., Brown, S. E., Filipovska, A., & Murphy, M. P. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.999 · Cited by 198
Amano, K., Leung, P. S. C., Rieger, R., Quan, C., Wang, X., Marik, J., Suen, Y. F., Kurth, M. J., Nantz, M. H., Ansari, A. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5874 · Cited by 187
Garcia, J., Han, D., Sancheti, H., Yap, L.-P., Kaplowitz, N., & Cadenas, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164160 · Cited by 183
Kumagi, T., & Heathcote, E. J. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-1 · Cited by 182
Hohenester, S. D., Elferink, R. P. J. O., & Beuers, U. H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0164-5 · Cited by 178
Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
Beuers, U. H., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E., Lindor, K. D., Ma, X., Mackay, I. R., Parés, A. R., Tanaka, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.031 · Cited by 173
Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’
Beuers, U. H., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E., Lindor, K. D., Ma, X., Mackay, I. R., Parés, A. R., Tanaka, A., et al. (2015) · Hepatology · doi:10.1002/hep.28140 · Cited by 165
S-Glutathionylation signaling in cell biology: Progress and prospects
Pastore, A., & Piemonte, F. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.03.010 · Cited by 170
Selmi, C. F., Leung, P. S. C., Sherr, D. H., Diaz, M., Nyland, J. F., Monestier, M., Rose, N. R., & Gershwin, M. E. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.007 · Cited by 160
Juran, B. D., Hirschfield, G. M., Invernizzi, P., Atkinson, E. J., Li, Y., Xie, G., Kosoy, R., Ransom, M., Sun, Y., Bianchi, I., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds359 · Cited by 150
“The mechanisms whereby the biliary epithelia is specifically targeted for immunologic damage in PBC are not well understood, but it has been suggested that an inability of BECs to glutathiolate PDC-E2 during cell apoptosis may result in aberrant persistence of immunogenic PDC-E2 antigens and downstream priming and act…”
BackgroundSelf-citationThe consequences of apoptosis in autoimmunity
Lleò, A., Selmi, C. F., Invernizzi, P., Podda, M., & Gershwin, M. E. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.04.009 · Cited by 140
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review
Lleò, A., Leung, P. S. C., Hirschfield, G. M., & Gershwin, E. M. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1697617 · Cited by 142
Lleo, A., Liao, J., Invernizzi, P., Zhao, M., Bernuzzi, F., Ma, L., Lanzi, G., Ansari, A. A., Coppel, R. L., Zhang, P., et al. (2012) · Hepatology · doi:10.1002/hep.24630 · Cited by 133
Models of Drug Induced Liver Injury (DILI)—Current Issues and Future Perspectives
Kuna, L., Bozic, I., Kizivat, T., Bojanic, K., Mrso, M., Kralj, E., Smolic, R., Wu, G. Y., & Smolic, M. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180523095355 · Cited by 127
Hepatoimmunology: A perspective
Mackay, I. R. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01063.x · Cited by 131
Protein S-glutathiolation: Redox-sensitive regulation of protein function
Hill, B. G., & Bhatnagar, A. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.009 · Cited by 123
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis
Leung, P. S. C., Rossaro, L., Davis, P. A., Park, O., Tanaka, A., Kikuchi, K., Miyakawa, H., Norman, G. L., Lee, W., & Gershwin, E. M. (2007) · Hepatology · doi:10.1002/hep.21828 · Cited by 121
Novel therapeutic targets in primary biliary cirrhosis
Dyson, J. K., Hirschfield, G. M., Adams, D. H., Beuers, U., Mann, D. A., Lindor, K. D., & Jones, D. E. J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.12 · Cited by 120
Pathogenesis of primary biliary cirrhosis
Jones, D. E. (2007) · Postgraduate Medical Journal · doi:10.1136/gut.2007.122150 · Cited by 118
Selmi, C. F., Ross, S. R., Ansari, A. A., Invernizzi, P., Podda, M., Coppel, R. L., & Gershwin, M. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.033 · Cited by 108
Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
Wree, A., Dechêne, A., Herzer, K., Hilgard, P., Syn, W.-K., Gerken, G., & Canbay, A. (2011) · Digestion · doi:10.1159/000322298 · Cited by 93
Padgett, K. A., Selmi, C. F., Kenny, T. P., Leung, P. S. C., Balkwill, D. L., Ansari, A. A., Coppel, R. L., & Gershwin, M. E. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.01.012 · Cited by 102
Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’
Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.031 · Cited by 97
Erice, O., Muñoz-Garrido, P., Vaquero, J., Perugorria, M. J., Fernández‐Barrena, M. G., Sáez, E., Santos‐Laso, Á., Arbelaiz, A., Jiménez-Agüero, R., Fernández‐Irigoyen, J., et al. (2017) · Hepatology · doi:10.1002/hep.29533 · Cited by 96
Self-citationApoptosis in liver diseases--detection and therapeutic applications.
Ghavami, S., Hashemi, M. M., Kadkhoda, K., Alavian, S. M., Bay, G. H., & Łoś, M. (2005) · PubMed · Cited by 96
T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis
Allina, J., Hu, B., Sullivan, D. M., Fiel, M. I., Thung, S. N., Bronk, S. F., Huebert, R. C., de Water, J. V., LaRusso, N. F., Gershwin, M. E., et al. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.11.004 · Cited by 95
Self-citationInduction of Primary Biliary Cirrhosis in Guinea Pigs following Chemical Xenobiotic Immunization
Leung, P. S. C., Park, O., Tsuneyama, K., Kurth, M. J., Lam, K. S., Ansari, A. A., Coppel, R. L., & Gershwin, M. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2651 · Cited by 94
Etiopathogenesis of primary biliary cirrhosis
Lleò, A., Invernizzi, P., Mackay, I. R., Prince, H., Zhong, R., & Gershwin, M. E. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3328 · Cited by 94
Matsumura, S., de Water, J. V., Leung, P. S. C., Odin, J. A., Yamamoto, K., Gores, G. J., Mostov, K. E., Ansari, A. A., Coppel, R. L., Shiratori, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20175 · Cited by 94
Self-citationHarada, K., Isse, K., Kamihira, T., Shimoda, S., & Nakanuma, Y. (2005) · Hepatology · doi:10.1002/hep.20705 · Cited by 88
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Chen, G., Chen, Z., Hu, Y., & Huang, P. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4170 · Cited by 89
Natural killer cells regulate T cell immune responses in primary biliary cirrhosis
Shimoda, S., Hisamoto, S., Harada, K., Iwasaka, S., Chong, Y., Nakamura, M., Bekki, Y., Yoshizumi, T., Shirabe, K., Ikegami, T., et al. (2015) · Hepatology · doi:10.1002/hep.28122 · Cited by 82
Bizzaro, N., Covini, G., Rosina, F., Muratori, P., Tonutti, E., Villalta, D., Pesente, F., Alessio, M. G., Tampoia, M., Antico, A., et al. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8234-y · Cited by 79
Schachna, L., Wigley, F. M., Morris, S. M., Gelber, A. C., Rosen, A., & Casciola-Rosen, L. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10407 · Cited by 78
Self-citationOxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis
Salunga, T. L., Cui, Z., Shimoda, S., Zheng, H.-C., Nomoto, K., Kondo, T., Takano, Y., Selmi, C. F., Alpini, G. D., Gershwin, M. E., et al. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.04.002 · Cited by 76
The role of environmental factors in primary biliary cirrhosis
Selmi, C. F., & Gershwin, M. E. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.006 · Cited by 74
Mechanisms of tissue injury in autoimmune liver diseases
Liaskou, E., Hirschfield, G. M., & Gershwin, M. E. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0439-3 · Cited by 74
Update on primary biliary cirrhosis
Invernizzi, P., Selmi, C. F., & Gershwin, M. E. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.02.014 · Cited by 70
Calmus, Y., & Poupon, R. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.07.007 · Cited by 69
Sasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2012) · Liver International · doi:10.1111/liv.12049 · Cited by 69
Environment and primary biliary cirrhosis: Electrophilic drugs and the induction of AMA
Leung, P. S. C., Wang, J., Naiyanetr, P., Kenny, T. P., Lam, K. S., Kurth, M. J., & Gershwin, M. E. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.007 · Cited by 66
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis
Chen, R. C. Y., Naiyanetr, P., Shu, S.-A., Wang, J., Yang, G., Kenny, T. P., Guggenheim, K. G., Butler, J. D., Bowlus, C. L., Tao, M., et al. (2012) · Hepatology · doi:10.1002/hep.26157 · Cited by 65
Experimental evidence on the immunopathogenesis of primary biliary cirrhosis
Selmi, C. F., Meda, F., Kasangian, A. A., Invernizzi, P., Tian, Z., Lian, Z., Podda, M., & Gershwin, M. E. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.104 · Cited by 63
Pathogenesis of primary biliary cirrhosis
Jones, D. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00270-8 · Cited by 62
Primary biliary cirrhosis: What do autoantibodies tell us?
Hu, C. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i29.3616 · Cited by 61
Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P. R., & Boilard, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01026 · Cited by 59
Pathogenesis of Primary Biliary Cirrhosis
Jones, D. E. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.004 · Cited by 58
New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis
He, X.-S., Ansari, A. A., Ridgway, W. M., Coppel, R. L., & Gershwin, M. E. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.04.006 · Cited by 58
Apoptosis and the liver: relation to autoimmunity and related conditions
Bai, J., & Odin, J. A. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00125-8 · Cited by 56
Self-citationApoptosis induction by eIF5A1 involves activation of the intrinsic mitochondrial pathway
Sun, Z., Cheng, Z., Taylor, C. A., McConkey, B. J., & Thompson, J. E. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22100 · Cited by 57
Sasaki, M., Ikeda, H., & Nakanuma, Y. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.03.005 · Cited by 55
Geng, Y., Walls, K. C., Ghosh, A. P., Akhtar, R. S., Klocke, B. J., & Roth, K. A. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.954024 · Cited by 54
Small ubiquitin‐related modifiers
Janka, C., Selmi, C. F., Gershwin, M. E., Will, H., & Sternsdorf, T. (2005) · Hepatology · doi:10.1002/hep.20619 · Cited by 54
Mao, T. K., Davis, P. A., Odin, J. A., Coppel, R. L., & Gershwin, E. M. (2004) · Hepatology · doi:10.1002/hep.20491 · Cited by 52
Self-citationRole of Cholangiocytes in Primary Biliary Cirrhosis
Lleò, A., Maroni, L., Glaser, S. S., Alpini, G. D., & Marzioni, M. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1383727 · Cited by 51
The Pathogenesis of Autoimmune Liver Disease
Arndtz, K., & Hirschfield, G. M. (2016) · Digestive Diseases · doi:10.1159/000444471 · Cited by 54
Pan, Y., Cao, M., You, D., Qin, G., & Liu, Z. (2019) · BioMed Research International · doi:10.1155/2019/1283824 · Cited by 51
Immunopathogenesis of Primary Biliary Cirrhosis
Nishio, A., Keeffe, E. B., & Gershwin, M. E. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-34506 · Cited by 51
Nakamura, M., Takii, Y., Ito, M., Komori, A., Yokoyama, T., Shimizu‐Yoshida, Y., Koyabu, M., Matsuyama, M. M., Mori, T., Kamihira, T., et al. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.10.007 · Cited by 50
The unfinished business of primary biliary cirrhosis
Selmi, C. F., Zuin, M. G., & Gershwin, M. E. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.006 · Cited by 49
Pluripotent Stem Cell–Derived Hepatocytes: Potential and Challenges in Pharmacology
Szkolnicka, D., Zhou, W., Lucendo‐Villarin, B., & Hay, D. C. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140306 · Cited by 51
Primary biliary cholangitis: pathogenic mechanisms
Prìeto, J., Bañales, J. M., & Medina, J. F. (2020) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000703 · Cited by 48
B cells and autoimmune liver diseases
Moritoki, Y., Lian, Z., Ohsugi, Y., Ueno, Y., & Gershwin, M. E. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.02.006 · Cited by 48
Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
Beuers, U. H., Gershwin, E. M., Gish, R. G., Invernizzi, P., Jones, D. E., Lindor, K. D., Ma, X., Mackay, I. R., Parés, A. R., Tanaka, A., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.312 · Cited by 47
Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity
Naiyanetr, P., Butler, J. D., Meng, L., Pfeiff, J., Kenny, T. P., Guggenheim, K. G., Reiger, R., Lam, K. S., Kurth, M. J., Ansari, A. A., et al. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.06.001 · Cited by 48
Primary Biliary Cirrhosis is More Severe in Overweight Patients
Híndi, M., Levy, C., Couto, C. A., Bejarano, P. A., & Mendes, F. D. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318261e659 · Cited by 45
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'
Beuers, U., Gershwin, M. E., Gish, R. G., Invernizzi, P., Jones, D. E. J., Lindor, K., Ma, X., Mackay, I. R., Parés, A., Tanaka, A., et al. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.08.001 · Cited by 43
Infectious Agents and Xenobiotics in the Etiology of Primary Biliary Cirrhosis
Selmi, C. F., Santis, M. D., Cavaciocchi, F., & Gershwin, M. E. (2010) · Disease Markers · doi:10.1155/2010/752314 · Cited by 41
Tsuneyama, K., Harada, K., Kono, N., Sasaki, M., Saito, T., Gershwin, M. E., Ikemoto, M., Arai, H., & Nakanuma, Y. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00105-8 · Cited by 41
The Clinical Significance of Posttranslational Modification of Autoantigens
Zavala-Cerna, M. G., Martínez-García, E. A., Torres-Bugarı́n, O., Rubio-Jurado, B., Riebeling, C., & Nava, A. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8424-0 · Cited by 40
Molecular mechanisms of cholangiopathy in primary biliary cirrhosis
Harada, K., & Nakanuma, Y. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0321-z · Cited by 38
Primary biliary cirrhosis and other ductopenic diseases
Burt, A. D. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00010-7 · Cited by 38
Kawata, K., Kobayashi, Y., Gershwin, M. E., & Bowlus, C. L. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8324-0 · Cited by 39
Rosen, A., & Casciola-Rosen, L. A. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500304 · Cited by 37
Self-citationRole of the Anion Exchanger 2 in the Pathogenesis and Treatment of Primary Biliary Cirrhosis
Medina, J. F. (2011) · Digestive Diseases · doi:10.1159/000324144 · Cited by 39
Nogiec, C., Burkart, A., Dreyfuss, J. M., Lerin, C., Kasif, S., & Patti, M.-E. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.12.012 · Cited by 34
Genes and (auto)immunity in primary biliary cirrhosis
Selmi, C. F., Invernizzi, P., Zuin, M. G., Podda, M., Seldin, M. F., & Gershwin, M. E. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364248 · Cited by 34
Macdonald, P. S., Palmer, J. M., Kirby, J. A., & Jones, D. E. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02484.x · Cited by 34
Concepcion, A. R., Salas, J. T., Sáez, E., Sarvide, S., Ferrer, A., Portu, A., Uriarte, I., Hervás‐Stubbs, S., Elferink, R. P. J. O., Prìeto, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5665 · Cited by 32
Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis
Allina, J., Stanca, C. M., Garber, J. J., Hu, B., Sautès‐Fridman, C., Bach, N., & Odin, J. A. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.10.003 · Cited by 32
Self-citation
Metadata
- Authors
- Odin, J. A., Huebert, R. C., Casciola-Rosen, L., LaRusso, N. F., & Rosen, A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Mayo Clinic (US)
- Johns Hopkins University (US)
- Corresponding author
- Odin, Joseph A.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-07-15
- Volume
- 108
- Issue
- 2
- Pages
- 223-232
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC203018
- OpenAlex
- W4249025813
- Cited by
- 220
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 10 · 2016: 5 · 2015: 20 · 2014: 9 · 2013: 9 · 2012: 14
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK059653, R01DK024031, T32DK-07832)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 44684, R01AR044684)
- National Institute of Dental and Craniofacial Research (R37DE012354, DE12354, R01DE012354)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- primary biliary cirrhosis, pyruvate dehydrogenase E2, autoantigens, autoantibodies, apoptosis, Bcl-2, glutathione depletion, bile duct epithelial cells, cholangiocytes, mitochondrial proteins, neoantigens, caspase cleavage
- MeSH terms
- Autoantibodies, Autoantigens, Bile Ducts, Cell Line, Dithiothreitol, Epithelial Cells, Fluorescent Antibody Technique, Glutathione, Humans, Immune Sera, Liver Cirrhosis, Biliary, Lymphocyte Activation, Mitochondria, Pyruvate Dehydrogenase Complex, Transfection, Immunoblotting, Gene Expression Regulation, Enzymologic, Apoptosis, Genes, bcl-2, Dihydrolipoyllysine-Residue Acetyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review